Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

Oncoimmunology · 2012 · PMC3382902 · PMID 22754761

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

tended toward significancep = 0.073so close (0.05 < p ≤ 0.1)

Divpenia tended toward significance (p = 0.073) ( Table S1 ).

also in 121 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.